Bisarylthiourea comprising cycloalkyl-thiophene-3-carboxylate derivatives as potential human toll-like receptor (TLR2) agonists: design, synthesis, and structure–activity relationship enabling the switch from TLR2/1 to TLR2/6 activation
RSC Medicinal Chemistry · 2026 · 17 (6) · 2886-2906
DOI: 10.1039/d5md01078k ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Munugala Chandrakanth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology Calicut Kozhikode - 673601 Kerala India janardhan@nitc.ac.in. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Science and Engineering Research Board, National Institute of Technology Calicut.
Abstract (Originalsprache)
A series of bisarylthiourea (BAT) comprising cycloalkyl-thiophene-3-carboxylate derivatives was rationally designed, synthesized, and evaluated as potential human TLR2 agonists.
Autor:innen und Institutionen
- Department of Chemistry, National Institute of Technology Calicut Kozhikode - 673601 Kerala India janardhan@nitc.ac.in.
- National Interdisciplinary Centre of Vaccine, Immunotherapeutics and Antimicrobials (NICOVIA), Panjab University Chandigarh - 160014 India nikolai.petrovsky@vaxine.net.
- Vaxine Pty Ltd. 11 Walkley Avenue Warradale South Australia 5046 Australia.
- Australian Respiratory and Sleep Medicine Institute Bedford Park South Australia 5042 Australia.
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Sector 67, S.A.S. Nagar Mohali 160 062 Punjab India.
- Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University Chandigarh - 160014 India.
ORCID-Profile: Janardhan Banothu
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- Science and Engineering Research Board
- National Institute of Technology Calicut
Zitieren
APA
Chandrakanth, M., Honda-Okubo, Y., C G, A., Salunke, D. B., Petrovsky, N., & Banothu, J. (2026). Bisarylthiourea comprising cycloalkyl-thiophene-3-carboxylate derivatives as potential human toll-like receptor (TLR2) agonists: design, synthesis, and structure–activity relationship enabling the switch from TLR2/1 to TLR2/6 activation. RSC Medicinal Chemistry, 17(6), 2886-2906. https://doi.org/10.1039/d5md01078k
Vancouver
Chandrakanth M, Honda-Okubo Y, C G A, Salunke DB, Petrovsky N, Banothu J. Bisarylthiourea comprising cycloalkyl-thiophene-3-carboxylate derivatives as potential human toll-like receptor (TLR2) agonists: design, synthesis, and structure–activity relationship enabling the switch from TLR2/1 to TLR2/6 activation. RSC Medicinal Chemistry. 2026;17(6):2886-2906. doi:10.1039/d5md01078k
BibTeX
@article{Chandrakanth2026,
author = {Chandrakanth, Munugala and Honda-Okubo, Yoshikazu and C G, Arya and Salunke, Deepak B and Petrovsky, Nikolai and Banothu, Janardhan},
title = {Bisarylthiourea comprising cycloalkyl-thiophene-3-carboxylate derivatives as potential human toll-like receptor (TLR2) agonists: design, synthesis, and structure–activity relationship enabling the switch from TLR2/1 to TLR2/6 activation},
journal = {RSC Medicinal Chemistry},
year = {2026},
volume = {17},
number = {6},
pages = {2886--2906},
doi = {10.1039/d5md01078k}
}
EUVIMED